Clinical Trials Browser

Phase EARLY_PHASE1 × Skin Neoplasms × binimetinib × Clear all

NCT03543969 2026-02-05

Adaptive BRAF-MEK Inhibitor Therapy for Advanced BRAF Mutant Melanoma

Phase EARLY_PHASE1 Active not recruiting

Melanoma, Skin Neoplasms